Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Liver Cirrhosis

Free Subscription 23.03.2026 1 BMC Gastroenterol 6 Hepatology 1 J Gastroenterol Hepatol 2 J Hepatol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. YANG K, Yang B, Chen J, Gao L, et al
   Clinicopathological features of hepatobiliary cells in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid.
   BMC Gastroenterol. 2026 Feb 12. doi: 10.1186/s12876-026-04686.
   PubMed         Abstract available
   
   

   
   Hepatology

2. SIDHU G
   When "trace" is not trivial: Mild ascites as the missing prognostic middle ground in cirrhosis.
   Hepatology. 2026;83:695-696.
   PubMed        
   
   
3. MARTINS A, Khakoo NS, Reddy A, Reynolds JM, et al
   Comparative effectiveness of peroxisome proliferator-activated receptor agonists as second-line therapies for primary biliary cholangitis: A systematic review and network meta-analysis.
   Hepatology. 2025 Jul 15. doi: 10.1097/HEP.0000000000001465.
   PubMed         Abstract available
   
   
4. XIE L, Chen H, Zhang L, Yang YY, et al
   Suppressing MASH fibrotic progression by blocking succinate-GPR91 signaling in hepatic stellate cells.
   Hepatology. 2025 May 19. doi: 10.1097/HEP.0000000000001405.
   PubMed         Abstract available
   
   
5. LOOMBA R, Daniel PCN, Amangurbanova M, Bettencourt R, et al
   Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsy.
   Hepatology. 2026;83:907-914.
   PubMed         Abstract available
   
   
6. WANG C, Dong D, Zhao N, Zhao S, et al
   Hepatocyte-specific C-C motif chemokine ligand 9 signaling promotes liver fibrosis progression in mice.
   Hepatology. 2025 May 9. doi: 10.1097/HEP.0000000000001393.
   PubMed         Abstract available
   
   
7. PREMKUMAR M, Karvellas CJ, Kulkarni AV, Bhujade H, et al
   Role of Point-of-Care ultrasound (POCUS) in clinical hepatology.
   Hepatology. 2024 Jul 1. doi: 10.1097/HEP.0000000000000990.
   PubMed         Abstract available
   
   

   
   J Gastroenterol Hepatol

8. MIN EK, Kim SS, Ahn B, Kim DG, et al
   Diagnostic Value of MR Elastography and MRI-Proton Density Fat Fraction in Cirrhosis Based on Explant Liver Histology.
   J Gastroenterol Hepatol. 2026 Mar 13. doi: 10.1111/jgh.70316.
   PubMed         Abstract available
   
   

   
   J Hepatol

9. LUUKKONEN PK
   Targeting metabolism to modify cirrhosis: Lessons from FGF21 therapy in MASH.
   J Hepatol. 2026 Mar 19:S0168-8278(26)00131-5. doi: 10.1016/j.jhep.2026.
   PubMed        
   
   
10. LACKNER C, Gouw ASH, Avancini Ferreira Alves V, Arola J, et al
    Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials.
    J Hepatol. 2026;84:693-701.
    PubMed         Abstract available
    
    

    
    PLoS One

11. ZHANG J, Feng L
    Analysis of 6-week mortality and influencing factors in patients with liver cirrhosis and portal vein thrombosis complicated by acute gastrointestinal bleeding.
    PLoS One. 2026;21:e0345079.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum